Merck Keytruda Rivalry Surges as Ivonescimab Stumbles

1 month ago

Merck Terns Acquisition $6.7B Surge as Keytruda Cliff Nears

3 months ago

Merck KGaA Forecast Warning: 2026 Profit Hit Looms

3 months ago

Merck Dividend Strategy Opportunity: Can It Withstand the Keytruda Patent Shock in 2028?

4 months ago